Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for memory and attention in mild cognitive impairment
NL-OMON41157Recruiting
- Sponsor
- Maastricht University
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of methylphenidate in Mild Cognitive Impairment (MCI) (2 arms), sponsored by Maastricht University. Primary endpoints: Immediate verbal learning recall, Delayed verbal learning recall and 4 more. Started Jun 2015; status: recruiting.
02
Drugs
methylphenidate
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NL-OMON41157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41157.